{"id":7685,"date":"2025-06-27T16:52:56","date_gmt":"2025-06-27T13:52:56","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=7685"},"modified":"2025-06-27T16:52:56","modified_gmt":"2025-06-27T13:52:56","slug":"scientific-summary-the-head-and-the-heart","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/scientific-summary-the-head-and-the-heart\/","title":{"rendered":"Scientific Summary: \u201cThe Head and the Heart\u201d"},"content":{"rendered":"
Scientific Summary: \u201cThe Head and the Heart\u201d<\/div>\n
Published June 6, 2025, Medscape<\/div>\n
<\/div>\n
Overview<\/div>\n
<\/div>\n
This article highlights the disproportionately high cardiovascular morbidity and mortality among patients with psychiatric conditions and advocates for a collaborative, multidisciplinary approach to care.<\/div>\n
1. Burden of Cardiovascular Disease in Mental Illness<\/div>\n
\u2022 Individuals with severe mental illness have a 15\u201320 year shorter life expectancy, largely due to CVD.<\/span><\/div>\n
\u2022 Depression increases both the risk of developing CVD (2\u20134x) and mortality after cardiac events.<\/span><\/div>\n
\u2022 There remains a clinical gap: psychiatrists often overlook cardiovascular risks, and cardiologists frequently neglect mental health symptoms.<\/span><\/div>\n
2. Shared Biological Mechanisms<\/div>\n
\u2022 The overlap between CVD and psychiatric illness includes:<\/span><\/div>\n
\u2022 Inflammation, HPA-axis (Hypothalamic\u2013Pituitary\u2013Adrenal axis)dysregulation, autonomic imbalance, reduced heart rate variability, platelet dysfunction, and shared genetic vulnerabilities.<\/span><\/div>\n
\u2022 Stress, sleep disorders, and sympathetic overactivity further amplify cardiovascular risk.<\/span><\/div>\n
3. Medication Interactions and Cardiac Effects<\/div>\n
<\/div>\n
A. Psychotropic Drugs\u2019 Cardiac Impacts<\/div>\n
\u2022 SSRIs are considered first-line for depressed cardiac patients due to safety, but:<\/span><\/div>\n
\u2022 May impair platelet function and interact with anticoagulants or antiplatelet agents.<\/span><\/div>\n
\u2022 Escitalopram and citalopram pose risks for QT prolongation and bradyarrhythmias.<\/span><\/div>\n
\u2022 Second-generation antipsychotics (SGAs) may cause:<\/span><\/div>\n
\u2022 QT prolongation, tachycardia, cardiomyopathy, and severe metabolic effects.<\/span><\/div>\n
\u2022 Olanzapine and clozapine are the most metabolically adverse; aripiprazole and ziprasidone have more favorable profiles.<\/span><\/div>\n
\u2022 Valproate and lithium also carry cardiometabolic risks (e.g., weight gain).<\/span><\/div>\n
<\/div>\n
B. Cardiac Drugs\u2019 Psychiatric Side Effects<\/div>\n
\u2022 Beta-blockers, ACE inhibitors, statins, and others may induce depression, anxiety, or sleep disturbances.<\/span><\/div>\n
4. Psychosocial and Systemic Contributors<\/div>\n
\u2022 Depression and stress impair medication adherence, physical activity, and dietary habits.<\/span><\/div>\n
\u2022 Socioeconomic factors (e.g., poverty, childhood trauma, limited access to care) compound both psychiatric and cardiac risk.<\/span><\/div>\n
\u2022 Healthcare system barriers include stigma, discrimination, and unequal access to diagnostics and timely treatment.<\/span><\/div>\n
5. Recommendations and Best Practices<\/div>\n
<\/div>\n
A. Screening & Referral<\/div>\n
\u2022 Use PHQ-2 and GAD-2 for depression\/anxiety screening in cardiac patients.<\/span><\/div>\n
\u2022 Cardiologists should feel empowered to identify and gently refer patients for mental health support when needed.<\/span><\/div>\n
<\/div>\n
B. Behavioral Interventions & Psychosocial Support<\/div>\n
\u2022 Cognitive Behavioral Therapy (CBT) & stress reduction improve both psychiatric and cardiac outcomes.<\/span><\/div>\n
\u2022 Start psychiatric medications low and slow(Begin with a low dose and increase it gradually), with careful monitoring for cardiometabolic effects.<\/span><\/div>\n
\u2022 Consider early metformin initiation with SGAs to mitigate metabolic effects.<\/span><\/div>\n
6. The Call for Collaborative Care<\/div>\n
\u2022 A team-based model integrating cardiologists, psychiatrists, primary care, and mental health professionals is essential.<\/span><\/div>\n
\u2022 All patients with:<\/span><\/div>\n
\u2022 Mental illness should be screened for CVD and metabolic syndrome.<\/span><\/div>\n
\u2022 Heart disease should be evaluated for depression, a major prognostic marker post-MI.<\/span><\/div>\n
7. A Bidirectional Healing Model<\/div>\n
\u2022 Mental and cardiovascular health are deeply interconnected:<\/span><\/div>\n
\u201cThe brain heals the heart \u2014 and the heart heals the brain.\u201d<\/div>\n
Addressing one improves outcomes for the other.<\/div>\n
<\/div>\n
https:\/\/click.mail.medscape.com\/?qs=dd8b5d719a915be138c0af2a559254f586ddb3fbbb42599522c90eaaea2a5fda9dad5a4c040d14bdffdad6772b6e12e8d04ba78644391674bcb1ad78a13b30b9<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

Scientific Summary: \u201cThe Head and the Heart\u201d Published June 6, 2025, Medscape Overview This article highlights the disproportionately high cardiovascular morbidity and mortality among patients with psychiatric conditions and advocates for a collaborative, multidisciplinary approach to care. 1. Burden of Cardiovascular Disease in Mental Illness \u2022 Individuals with severe mental illness have a 15\u201320 year […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7685","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7685","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=7685"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7685\/revisions"}],"predecessor-version":[{"id":7689,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7685\/revisions\/7689"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=7685"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=7685"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=7685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}